PL1733037T3 - Sposób wytwarzania polipeptydów - Google Patents

Sposób wytwarzania polipeptydów

Info

Publication number
PL1733037T3
PL1733037T3 PL05725198T PL05725198T PL1733037T3 PL 1733037 T3 PL1733037 T3 PL 1733037T3 PL 05725198 T PL05725198 T PL 05725198T PL 05725198 T PL05725198 T PL 05725198T PL 1733037 T3 PL1733037 T3 PL 1733037T3
Authority
PL
Poland
Prior art keywords
producing polypeptides
polypeptides
producing
Prior art date
Application number
PL05725198T
Other languages
English (en)
Inventor
Susan Leung Woon-Lam
James R Swartz
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of PL1733037T3 publication Critical patent/PL1733037T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/32—Processes using, or culture media containing, lower alkanols, i.e. C1 to C6
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL05725198T 2004-03-11 2005-03-10 Sposób wytwarzania polipeptydów PL1733037T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55267804P 2004-03-11 2004-03-11
PCT/US2005/007880 WO2005087802A2 (en) 2004-03-11 2005-03-10 Process for producing polypeptides
EP05725198.5A EP1733037B1 (en) 2004-03-11 2005-03-10 Process for producing polypeptides

Publications (1)

Publication Number Publication Date
PL1733037T3 true PL1733037T3 (pl) 2015-04-30

Family

ID=34976293

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05725198T PL1733037T3 (pl) 2004-03-11 2005-03-10 Sposób wytwarzania polipeptydów

Country Status (21)

Country Link
US (4) US7294483B2 (pl)
EP (1) EP1733037B1 (pl)
JP (1) JP5014116B2 (pl)
KR (1) KR101210083B1 (pl)
CN (1) CN1954074B (pl)
AU (1) AU2005222397A1 (pl)
BR (1) BRPI0507233B8 (pl)
CA (2) CA2946323A1 (pl)
DK (1) DK1733037T3 (pl)
ES (1) ES2527291T3 (pl)
HR (1) HRP20150077T1 (pl)
IL (1) IL177488A0 (pl)
ME (1) ME02058B (pl)
NZ (1) NZ549266A (pl)
PL (1) PL1733037T3 (pl)
PT (1) PT1733037E (pl)
RS (1) RS53774B1 (pl)
RU (1) RU2433185C2 (pl)
SI (1) SI1733037T1 (pl)
WO (1) WO2005087802A2 (pl)
ZA (1) ZA200606913B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2527291T3 (es) 2004-03-11 2015-01-22 Genentech, Inc. Proceso para la producción de polipéptidos
WO2007031580A1 (de) * 2005-09-15 2007-03-22 Continental Teves Ag & Co. Ohg Verfahren und vorrichtung zum prädizieren einer bewegungstrajektorie
JP2009095237A (ja) 2006-02-02 2009-05-07 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
JP6362543B2 (ja) 2012-02-23 2018-07-25 ジュノ セラピューティクス ゲーエムベーハー 細胞および他の複雑な生物学的材料のクロマトグラフィーによる単離
WO2016090251A1 (en) 2014-12-05 2016-06-09 Alexion Pharmaceuticals, Inc. Treating seizure with recombinant alkaline phosphatase
US10603361B2 (en) 2015-01-28 2020-03-31 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
AU2016308624B2 (en) 2015-08-17 2022-06-23 Alexion Pharmaceuticals, Inc. Manufacturing of alkaline phosphatases
CN108474791B (zh) 2015-10-22 2022-07-08 朱诺治疗学有限公司 培养细胞的方法及用于该方法的试剂盒和设备
HK1258932A1 (zh) 2015-10-22 2019-11-22 Juno Therapeutics Gmbh 用於转导的方法、反应剂盒、反应剂和设备
JP2018533571A (ja) 2015-10-30 2018-11-15 アレクシオン ファーマシューティカルズ， インコーポレイテッド 患者の頭蓋縫合早期癒合症を治療するための方法
KR20180125979A (ko) 2016-04-01 2018-11-26 알렉시온 파마슈티칼스, 인코포레이티드 알칼리성 포스파타아제로 근육 약화의 치료
MX2019011508A (es) 2017-03-31 2019-11-01 Alexion Pharma Inc Metodos para tratar la hipofosfatasia (hpp) en adultos y adolescentes.
MA49288A (fr) 2017-04-27 2020-03-04 Juno Therapeutics Gmbh Reactifs particulaires oligomères et leurs méthodes d'utilisation
US11913039B2 (en) 2018-03-30 2024-02-27 Alexion Pharmaceuticals, Inc. Method for producing recombinant alkaline phosphatase
JP7820148B2 (ja) 2018-08-10 2026-02-25 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼを用いて神経線維腫症１型および関連状態を治療する方法
EP3874024A1 (en) 2018-10-31 2021-09-08 Juno Therapeutics GmbH Methods for selection and stimulation of cells and apparatus for same
MX2022007114A (es) 2019-12-09 2022-07-11 Alexion Pharma Inc Polipeptidos de fosfatasa alcalina y metodos de uso de los mismos.
MX2023002673A (es) 2020-09-04 2023-05-12 Alexion Pharma Inc Métodos para el tratamiento de trastornos de mineralización ósea.
US12426594B2 (en) 2020-09-24 2025-09-30 Everest Medical Innovation GmbH Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
US12453805B2 (en) 2020-09-24 2025-10-28 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery
EP4291224A4 (en) 2021-02-12 2025-01-01 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof
CN113308393A (zh) * 2021-04-20 2021-08-27 上田环境修复有限公司 一种降解氨氮和总氮的制剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304472A (en) * 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5342763A (en) 1992-11-23 1994-08-30 Genentech, Inc. Method for producing polypeptide via bacterial fermentation
WO1996040935A1 (en) * 1995-06-07 1996-12-19 Bioteknologisk Institut Recombinant hexose oxidase, a method of producing same and use of such enzyme
KR100510234B1 (ko) 1995-06-29 2005-11-25 임뮤넥스 코포레이션 세포소멸을 유도하는 시토킨
US6030945A (en) 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
AU756759B2 (en) 1997-06-26 2003-01-23 Immunex Corporation Protein that binds trail
RU2139343C1 (ru) * 1997-10-31 1999-10-10 Государственный научный центр прикладной микробиологии Питательная среда для выделения возбудителя геморрагического колита с гемолитико-уремическим синдромом, вызываемого кишечной палочкой 0157:н7 (сорбитол e.coli 0157:н7агар)
JP4707237B2 (ja) * 1999-03-17 2011-06-22 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 外因性アミノ酸および新規ａｔｐ再生システムを用いたインビトロ高分子生合成の方法
US6337191B1 (en) * 1999-03-22 2002-01-08 The Board Of Trustees Of The Leland Stanford Junior University Vitro protein synthesis using glycolytic intermediates as an energy source
CA2369451C (en) 1999-04-08 2009-09-22 Genentech, Inc. Composition based on oppositely-charged polypeptides
JP5118796B2 (ja) 1999-06-28 2013-01-16 ジェネンテック， インコーポレイテッド 二価の金属イオンを利用したＡｐｏ−２リガンドの製造方法
RU2165455C1 (ru) * 1999-11-23 2001-04-20 Государственный научно-исследовательский институт особо чистых биопрепаратов РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pSS5, КОДИРУЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО ЧЕЛОВЕЧЕСКОГО АЛЬФА-2b ИНТЕРФЕРОНА, ШТАММ ESCHERICHIA COLI SS5 - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ЧЕЛОВЕЧЕСКОГО АЛЬФА-2b ИНТЕРФЕРОНА И СПОСОБ ПОЛУЧЕНИЯ ИНТЕРФЕРОНА АЛЬФА-2b
JP2004513652A (ja) 2000-11-14 2004-05-13 ザ　ボード　オブ　トラスティーズ　オブ　ザ　リーランド　スタンフォード　ジュニア　ユニバーシティ エネルギー源として解糖中間体を使用するインビトロにおけるタンパク質合成方法
PL206286B1 (pl) * 2001-09-13 2010-07-30 Genentech Incgenentech Inc Komórka Gram-ujemnej bakterii, sposób wytwarzania heterologicznego peptydu, sposób zapobiegania odcinaniu N-końcowego aminokwasu, sposób odcinania N-końcowego aminokwasu i sposób wytwarzania skróconego polipeptydu
JP2006506985A (ja) * 2002-10-30 2006-03-02 ファイザー・プロダクツ・インク コンパニオンアニマルのガンを診断および治療するための方法および組成物
ES2527291T3 (es) * 2004-03-11 2015-01-22 Genentech, Inc. Proceso para la producción de polipéptidos

Also Published As

Publication number Publication date
JP2007537725A (ja) 2007-12-27
US8389242B2 (en) 2013-03-05
US7294483B2 (en) 2007-11-13
WO2005087802A3 (en) 2006-03-02
RU2006135933A (ru) 2008-04-20
US20110059484A1 (en) 2011-03-10
EP1733037B1 (en) 2014-11-05
ZA200606913B (en) 2008-03-26
KR20070029144A (ko) 2007-03-13
US20070026496A1 (en) 2007-02-01
SI1733037T1 (sl) 2015-02-27
CA2558911C (en) 2016-12-06
JP5014116B2 (ja) 2012-08-29
NZ549266A (en) 2008-07-31
HRP20150077T1 (hr) 2015-04-10
IL177488A0 (en) 2006-12-10
DK1733037T3 (en) 2015-01-12
WO2005087802A2 (en) 2005-09-22
BRPI0507233A (pt) 2007-06-26
US20050244927A1 (en) 2005-11-03
AU2005222397A1 (en) 2005-09-22
RS53774B1 (sr) 2015-06-30
US20130236930A1 (en) 2013-09-12
CN1954074B (zh) 2011-08-24
BRPI0507233B1 (pt) 2018-01-23
RU2433185C2 (ru) 2011-11-10
HK1103761A1 (en) 2007-12-28
CN1954074A (zh) 2007-04-25
KR101210083B1 (ko) 2012-12-07
PT1733037E (pt) 2015-02-05
EP1733037A2 (en) 2006-12-20
BRPI0507233B8 (pt) 2021-05-25
CA2946323A1 (en) 2005-09-22
ES2527291T3 (es) 2015-01-22
ME02058B (me) 2015-05-20
CA2558911A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
GB0416001D0 (en) Process
GB0407329D0 (en) Process
IL177488A0 (en) Process for producing polypeptides
IL178233A0 (en) Process for producing 5-hydroxy-4-thiomethylpyrazole derivatives
GB0413053D0 (en) Process
GB0404793D0 (en) Process
GB0512861D0 (en) Process
EP1767538A4 (en) PROCESS FOR PREPARING A 1-OXACEPHALOSPORIN-7ALPHA-METHOXY-3-CHLOROMETHYL DERIVATIVE
GB0410289D0 (en) Process
GB0406894D0 (en) Process
ZA200704972B (en) Processes for producing 4-aminoquinazolines
GB0412875D0 (en) Process
GB0427022D0 (en) Process
GB0414335D0 (en) Process
IL183804A0 (en) Process for preparing substituted 2-alkoxycarbonyl-3-aminothiophenes
HUP0400517A3 (en) Process for producing cabergoline
GB0427021D0 (en) Process
IL180189A (en) Process for producing (z)-1-phenyl-1-diethylaminocarbonyl-2-hydroxymethylcyclopropane
EP1786764A4 (en) PROCESS FOR PREPARING TAMSULOSINE
GB0411583D0 (en) Process
GB0411185D0 (en) Process
GB2413325B (en) Process for producing 2-benzoyloxyacetaldehyde derivative
GB0420561D0 (en) Process
GB0401540D0 (en) Process
GB0413084D0 (en) Process